Stock Track | Telix Pharmaceuticals Soars 5.59% Intraday on Strong Revenue Guidance

Stock Track
02/20

TELIX PHARMACEUTICALS LTD (TLX.AU) stock soared 5.59% during intraday trading on Friday, reflecting strong investor sentiment.

The surge follows the company's release of its full-year revenue results and forward guidance. Telix reported FY revenue of US$803.8 million and provided FY 2026 group revenue guidance of US$950 million to US$970 million, indicating robust expected growth. Additionally, the company reported a non-material loss before tax of US$5.3 million for the period.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10